Hershman In the first trial, Southwest Oncology Group (SWOG) protocol S0715, investigators led by Dr
OB+/DM: 1.29 0.18) ( P = 0.004) and DPP-4 (OB+/DM+: 1.18 0.34
One of the reasons he left LifeVantage in 2013, he said, was its tendency to prioritize marketing concerns over scientific ones
In a study comparing the effects of semaglutide and tirzepatide for weight loss, those receiving tirzepatide were more likely to achieve 5% or greater, 10% or greater, and 15% or greater weight loss and experienced larger reductions in body weight at 3, 6, and 12 months
Studies show that people who followed this advice while taking GLP-1 drugs lost more weight, adhered better to a healthier lifestyle, and were more likely to sustain weight loss even after halting GLP-1 drugs